Pimco: Cleared for take-off


Being among the first buy-side derivatives users to start clearing over-the-counter products is a double-edged sword. On the one hand, a firm has a chance to shape the process; on the other, it has to devote extra resources to dealing with bumps in the road. Bill De Leon, global head of portfolio risk management at US bond giant Pimco, says the pros outweigh the cons.

Although dozens of firms have tested the emerging client clearing framework for OTC derivatives, Pimco was the first to start

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

Switching CCP – How and why?

As uncertainty surrounding Brexit continues and the impacts of Covid-19-driven market volatility are analysed, it is essential for banks and their end-users to understand their clearing options, and how they can achieve greater capital and cross…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here